Geerdink, L. M., Bertram, H., & Hansmann, G. (2017). First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension. Pulm Circ.
استشهاد بنمط شيكاغوGeerdink, Lianne M., Harald Bertram, و Georg Hansmann. "First-in-child Use of the Oral Selective Prostacyclin IP Receptor Agonist Selexipag in Pulmonary Arterial Hypertension." Pulm Circ 2017.
MLA استشهادGeerdink, Lianne M., Harald Bertram, و Georg Hansmann. "First-in-child Use of the Oral Selective Prostacyclin IP Receptor Agonist Selexipag in Pulmonary Arterial Hypertension." Pulm Circ 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.